Quest for the right Drug
רמיפנטניל ב.בראון 1מ"ג REMIFENTANIL B.BRAUN 1 MG (REMIFENTANIL AS HYDROCHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
אין פרטים : POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION / INFUSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Pharmaceutical particulars : מידע רוקחי
6 PHARMACEUTICAL PARTICULARS 6.1 List of excipients Glycine Hydrochloric acid 6.2 Incompatibilities Remifentanil B.Braun should only be reconstituted and diluted with those infusion solutions recommended (see section 6.6). It should not be reconstituted, diluted or mixed with Lactated Ringer's Injection or Lactated Ringer's and 5% Dextrose Injection. Remifentanil B.Braun should not be mixed with propofol in the same infusion bag prior to administration. Administration of Remifentanil B.Braun into the same intravenous line with blood/serum/plasma is not recommended. Non-specific esterases in blood products may lead to the hydrolysis of remifentanil to its inactive metabolite. Remifentanil B.Braun should not be mixed with other therapeutic agents prior to administration. 6.3 Shelf life The expiry date of the product is indicated on the packaging materials. 6.4 Special precautions for storage Store at or below 25°C. Do not refrigerate or freeze. The reconstituted solution of Remifentanil B.Braun is chemically and physically stable for 24 hours at room temperature (25°C). From a microbiological point of view, the product should be used immediately. In-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution has taken place in controlled and validated aseptic conditions. Any unused material should be discarded. 6.5 Nature and contents of container Remifentanil B.Braun for Injection 1 mg for intravenous use is available as 1 mg of Remifentanil lyophilised powder in 4 ml vials, in cartons of 5. Remifentanil B.Braun for Injection 2 mg for intravenous use is available as 2 mg of Remifentanil lyophilised powder in 6 ml vials, in cartons of 5. Remifentanil B.Braun for Injection 5 mg for intravenous use is available as 5 mg of Remifentanil lyophilised powder in 10 ml vials, in cartons of 5. 6.6 Special precautions for disposal Remifentanil B.Braun should be prepared for intravenous use by adding, as appropriate 1, 2, or 5 ml of diluent (according to the list below) to give a reconstituted solution with a concentration of 1 mg/ml remifentanil. One of the following diluents should be used for reconstitution: Water for Injections Glucose 5% solution for injection Glucose 5% and Sodium Chloride 0.9% solution for injection Sodium Chloride 0.9% solution for injection Sodium Chloride 0.45% solution for injection The reconstituted solution is clear, colourless, and practically free from particulate material. After reconstitution, visually inspect the product (where the container permits) for particulate material, discolouration or damage of container. Discard any solution where such defects are observed. Reconstituted product is for single use only. Any unused material should be discarded. After reconstitution, Remifentanil B. Braun may be further diluted. Remifentanil B.Braun should not be administered by manually-controlled infusion without further dilution to concentrations of 20 to 250 micrograms/ml (50 micrograms/ml is the recommended dilution for adults). The dilution is dependent upon the technical capability of the infusion device and the anticipated requirements of the patient. Any unused medicinal product or waste material should be disposed of in accordance with local requirements. The following tables give guidelines for infusion rates of Remifentanil B.Braun for manually controlled infusion: Table 1. Remifentanil B.Braun for Injection Infusion Rates (ml/kg/h) Drug Infusion Delivery Rate (ml/kg/h) for Solution Concentrations of Delivery 20 25 50 250 Rate micrograms/ml micrograms/ml micrograms/ml micrograms/ml 1 mg/50 ml 1 mg/40 ml 1 mg/20 ml 10 mg/40 ml 0.0125 0.038 0.03 0.015 Not recommended 0.025 0.075 0.06 0.03 Not recommended 0.05 0.15 0.12 0.06 0.012 0.075 0.23 0.18 0.09 0.018 0.1 0.3 0.24 0.12 0.024 0.15 0.45 0.36 0.18 0.036 0.2 0.6 0.48 0.24 0.048 0.25 0.75 0.6 0.3 0.06 0.5 1.5 1.2 0.6 0.12 0.75 2.25 1.8 0.9 0.18 1.0 3.0 2.4 1.2 0.24 1.25 3.75 3.0 1.5 0.3 1.5 4.5 3.6 1.8 0.36 1.75 5.25 4.2 2.1 0.42 2.0 6.0 4.8 2.4 0.48 Table 2. Remifentanil B.Braun for Injection Infusion Rates (ml/h) for a 20 micrograms/ml Solution Infusion Patient Weight (kg) Rate 5 10 20 30 40 50 60 (micrograms /kg/ min) 0.0125 0.188 0.375 0.75 1.125 1.5 1.875 2.25 0.025 0.375 0.75 1.5 2.25 3.0 3.75 4.5 0.05 0.75 1.5 3.0 4.5 6.0 7.5 9.0 0.075 1.125 2.25 4.5 6.75 9.0 11.25 13.5 0.1 1.5 3.0 6.0 9.0 12.0 15.0 18.0 0.15 2.25 4.5 9.0 13.5 18.0 22.5 27.0 0.2 3.0 6.0 12.0 18.0 24.0 30.0 36.0 0.25 3.75 7.5 15.0 22.5 30.0 37.5 45.0 0.3 4.5 9.0 18.0 27.0 36.0 45.0 54.0 0.35 5.25 10.5 21.0 31.5 42.0 52.5 63.0 0.4 6.0 12.0 24.0 36.0 48.0 60.0 72.0 Table 3. Remifentanil B.Braun for Injection Infusion Rates (ml/h) for a 25 micrograms/ml Solution Infusion Rate Patient Weight (kg) (micrograms 10 20 30 40 50 60 70 80 90 100 /kg/min) 0.0125 0.3 0.6 0.9 1.2 1.5 1.8 2.1 2.4 2.7 3.0 0.025 0.6 1.2 1.8 2.4 3.0 3.6 4.2 4.8 5.4 6.0 0.05 1.2 2.4 3.6 4.8 6.0 7.2 8.4 9.6 10.8 12.0 0.075 1.8 3.6 5.4 7.2 9.0 10.8 12.6 14.4 16.2 18.0 0.1 2.4 4.8 7.2 9.6 12.0 14.4 16.8 19.2 21.6 24.0 0.15 3.6 7.2 10.8 14.4 18.0 21.6 25.2 28.8 32.4 36.0 0.2 4.8 9.6 14.4 19.2 24.0 28.8 33.6 38.4 43.2 48.0 Table 4. Remifentanil B.Braun for Injection Infusion Rates (ml/h) for a 50 micrograms/ml Solution Infusion Rate Patient Weight (kg) (micrograms/kg/ 30 40 50 60 70 80 90 100 min) 0.025 0.9 1.2 1.5 1.8 2.1 2.4 2.7 3.0 0.05 1.8 2.4 3.0 3.6 4.2 4.8 5.4 6.0 0.075 2.7 3.6 4.5 5.4 6.3 7.2 8.1 9.0 0.1 3.6 4.8 6.0 7.2 8.4 9.6 10.8 12.0 0.15 5.4 7.2 9.0 10.8 12.6 14.4 16.2 18.0 0.2 7.2 9.6 12.0 14.4 16.8 19.2 21.6 24.0 0.25 9.0 12.0 15.0 18.0 21.0 24.0 27.0 30.0 0.5 18.0 24.0 30.0 36.0 42.0 48.0 54.0 60.0 0.75 27.0 36.0 45.0 54.0 63.0 72.0 81.0 90.0 1.0 36.0 48.0 60.0 72.0 84.0 96.0 108.0 120.0 1.25 45.0 60.0 75.0 90.0 105.0 120.0 135.0 150.0 1.5 54.0 72.0 90.0 108.0 126.0 144.0 162.0 180.0 1.75 63.0 84.0 105.0 126.0 147.0 168.0 189.0 210.0 2.0 72.0 96.0 120.0 144.0 168.0 192.0 216.0 240.0 Table 5. Remifentanil B.Braun for Injection Infusion Rates (ml/h) for a 250 micrograms/ml Solution Infusion Rate Patient Weight (kg) (micrograms/kg/ 30 40 50 60 70 80 90 100 min) 0.1 0.72 0.96 1.20 1.44 1.68 1.92 2.16 2.40 0.15 1.08 1.44 1.80 2.16 2.52 2.88 3.24 3.60 0.2 1.44 1.92 2.40 2.88 3.36 3.84 4.32 4.80 0.25 1.80 2.40 3.00 3.60 4.20 4.80 5.40 6.00 0.5 3.60 4.80 6.00 7.20 8.40 9.60 10.80 12.00 0.75 5.40 7.20 9.00 10.80 12.60 14.40 16.20 18.00 1.0 7.20 9.60 12.00 14.40 16.80 19.20 21.60 24.00 1.25 9.00 12.00 15.00 18.00 21.00 24.00 27.00 30.00 1.5 10.80 14.40 18.00 21.60 25.20 28.80 32.40 36.00 1.75 12.60 16.80 21.00 25.20 29.40 33.60 37.80 42.00 2.0 14.40 19.20 24.00 25.20 33.60 38.40 43.20 48.00
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לרופא
02.12.18 - עלון לרופאעלון מידע לצרכן
לתרופה במאגר משרד הבריאות
רמיפנטניל ב.בראון 1מ"ג